Drug profile · INN
dabigatran etexilate
DABIGATRAN ETEXILATE ACCORD
dabigatran etexilate (DABIGATRAN ETEXILATE ACCORD) is a thrombin inhibitor. Associated with Teva Pharma GmbH.
EMA: approved Blood and blood forming organs (B01) B01AE07
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — dabigatran etexilate
- Class
- Blood and blood forming organs (B01)
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.89
Quick answer
dabigatran etexilate (DABIGATRAN ETEXILATE ACCORD) is a thrombin inhibitor. Associated with Teva Pharma GmbH.
Key facts
INN dabigatran etexilate
Brand DABIGATRAN ETEXILATE ACCORD
Mechanism Thrombin inhibitor
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AE07
Originator Teva Pharma GmbH
Mechanism of action
Thrombin inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dabigatran etexilate?
dabigatran etexilate (DABIGATRAN ETEXILATE ACCORD) is a thrombin inhibitor. Associated with Teva Pharma GmbH.
What is the brand name for dabigatran etexilate?
DABIGATRAN ETEXILATE ACCORD is a marketed brand name for dabigatran etexilate. Check FDA Drugs@FDA for the current US label holder and prescribing information.